Abstract

3-deoxy-D-arabino-heptulosonate-7-phosphate synthase (DAHPS) is a key enzyme in the shikimate pathway for the biosynthesis of aromatic compounds. L-Phe and L-Tyr bind to the two main DAHPS isoforms and inhibit their enzyme activities, respectively. Synthetic biologists aim to relieve such inhibitions in order to improve the productivity of aromatic compounds. In this work, we reported a point mutant of yeast DHAPS, Aro3D154N, which retains the wild type enzyme activity but converts it highly inert to the inhibition by L-Phe. The Aro3 crystal structure along with the molecular dynamics simulations analysis suggests that the D154N mutation distant from the inhibitor binding cavity may reduce the binding affinity of L-Phe. Growth assays demonstrated that substitution of the conserved D154 with asparagine suffices to relieve the inhibition of L-Phe on Aro3, L-Tyr on Aro4, and the inhibitions on their corresponding homologues from diverse yeasts. The importance of our discovery is highlighted by the observation of 29.1% and 43.6% increase of yield for the production of tyrosol and salidroside respectively upon substituting ARO3 with ARO3D154N. We anticipate that this allele would be used broadly to increase the yield of various aromatic products in metabolically diverse microorganisms.

3-Deoxy-D-arabino-heptulosonate-7-phosphate synthase (DAHPS) is a key enzyme in the shikimate pathway for the biosynthesis of aromatic compounds, however, its activity is inhibited by L-Phe and L-Tyr. Here, the authors report the D154N point mutation of yeast DAHPS, which retains the wild type enzyme activity but relieves the inhibition by L-Phe, thus increasing the production of downstream aromatic amino acid derivatives.

Details

Title
Mechanistic investigation of a D to N mutation in DAHP synthase that dictates carbon flux into the shikimate pathway in yeast
Author
Liu, Huayi 1   VIAFID ORCID Logo  ; Xiao, Qingjie 2 ; Wu, Xinxin 3 ; Ma, He 3 ; Li, Jian 3 ; Guo, Xufan 3 ; Liu, Zhenyu 3 ; Zhang, Yan 4 ; Luo, Yunzi 1   VIAFID ORCID Logo 

 Tianjin University, Frontiers Science Center of Synthetic Biology and Key Laboratory of Systems Bioengineering (Ministry of Education), School of Chemical Engineering and Technology, Tianjin, China (GRID:grid.33763.32) (ISNI:0000 0004 1761 2484); Tianjin University, Georgia Tech Shenzhen Institute, Shenzhen, China (GRID:grid.33763.32) (ISNI:0000 0004 1761 2484) 
 Chinese Academy of Sciences, National Facility for Protein Science in Shanghai, Shanghai Advanced Research Institute (Zhangjiang Laboratory), Shanghai, China (GRID:grid.9227.e) (ISNI:0000000119573309) 
 Tianjin University, Frontiers Science Center of Synthetic Biology and Key Laboratory of Systems Bioengineering (Ministry of Education), School of Chemical Engineering and Technology, Tianjin, China (GRID:grid.33763.32) (ISNI:0000 0004 1761 2484) 
 Tianjin University, Tianjin Key Laboratory for Modern Drug Delivery & High-Efficiency, Collaborative Innovation Center of Chemical Science and Engineering, School of Pharmaceutical Science and Technology, Tianjin, China (GRID:grid.33763.32) (ISNI:0000 0004 1761 2484) 
Pages
152
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
23993669
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2837647679
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.